Literature DB >> 9271210

Genomic organization and functional characterization of the mouse GalR1 galanin receptor.

S Wang1, C He, M T Maguire, A L Clemmons, R E Burrier, M F Guzzi, C D Strader, E M Parker, M L Bayne.   

Abstract

Galanin mediates diverse physiological functions in digestive, endocrine, and central nervous systems through G-protein-coupled receptors. Two galanin receptors have been cloned but the gene structures are unknown. We report genomic and cDNA cloning of the mouse GalR1 galanin receptor and demonstrate that the coding sequence is uniquely divided into three exons encoding the N-terminal portion through the fifth transmebrane domain, the third intracellular loop, and the sixth transmembrane domain through the C-terminus. Functional analysis of the encoded cDNA revealed active ligand binding and intracellular signaling. The expression is detected in brain, spinal cord, heart and skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9271210     DOI: 10.1016/s0014-5793(97)00695-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

Review 1.  Central nervous system regulation of food intake and energy expenditure: role of galanin-mediated feeding behavior.

Authors:  Peng-Hua Fang; Mei Yu; Yin-Ping Ma; Jian Li; Yu-Mei Sui; Ming-Yi Shi
Journal:  Neurosci Bull       Date:  2011-12       Impact factor: 5.203

Review 2.  Exercise offers anxiolytic potential: a role for stress and brain noradrenergic-galaninergic mechanisms.

Authors:  Natale R Sciolino; Philip V Holmes
Journal:  Neurosci Biobehav Rev       Date:  2012-07-05       Impact factor: 8.989

3.  Cardiac ischemia-reperfusion regulates sympathetic neuropeptide expression through gp130-dependent and independent mechanisms.

Authors:  Eric N Alston; Diana C Parrish; Wohaib Hasan; Kevin Tharp; Laura Pahlmeyer; Beth A Habecker
Journal:  Neuropeptides       Date:  2010-10-28       Impact factor: 3.286

4.  Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons.

Authors:  Z Q Xu; X Ma; U Soomets; U Langel; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 5.  Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.

Authors:  Sven Ove Ogren; Eugenia Kuteeva; Tomas Hökfelt; Jan Kehr
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

6.  Alterations in the neuropeptide galanin system in major depressive disorder involve levels of transcripts, methylation, and peptide.

Authors:  Swapnali Barde; Joelle Rüegg; Josée Prud'homme; Tomas J Ekström; Miklos Palkovits; Gustavo Turecki; Gyorgy Bagdy; Robert Ihnatko; Elvar Theodorsson; Gabriella Juhasz; Rochellys Diaz-Heijtz; Naguib Mechawar; Tomas G M Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

7.  Galanin and neuropeptide Y reduce cholinergic transmission in the heart of the anaesthetised mouse.

Authors:  Margaret A Smith-White; Tiina P Iismaa; Erica K Potter
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

8.  Galanin negatively modulates opiate withdrawal via galanin receptor 1.

Authors:  Fiona E Holmes; Athena Armenaki; Tiina P Iismaa; Emily B Einstein; John Shine; Marina R Picciotto; David Wynick; Venetia Zachariou
Journal:  Psychopharmacology (Berl)       Date:  2011-10-04       Impact factor: 4.530

9.  Galanin receptors and ligands.

Authors:  Kristin E B Webling; Johan Runesson; Tamas Bartfai; Ulo Langel
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-07       Impact factor: 5.555

10.  Galanin inhibits GLP-1 and GIP secretion via the GAL1 receptor in enteroendocrine L and K cells.

Authors:  Arianna Psichas; Leslie L Glass; Stephen J Sharp; Frank Reimann; Fiona M Gribble
Journal:  Br J Pharmacol       Date:  2016-02-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.